Top-News
Gesundheitswesen USA

Cel-Sci Corp. News

Aktie
WKN:  A2DY0D ISIN:  US1508376076 US-Symbol:  CVM
1,54 €
+0,155 €
+11,19%
17:35:15 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
49,98 Mio.
Marktkapitalisierung *
66,26 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 14.12.2023

Cel-Sci Corp. News

14.02.24 - DGAP
Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
Original-​Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-...
05.12.23 - DGAP
Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
Original-​Research: CEL-SCI Corporation - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu CEL-SCI Corporation Unternehmen: CEL-...
18.07.23 - PR Newswire
Thinking about buying stock in Livent, Bitfarms, Altus Power, Bright Minds Biosciences, or CEL-SCI Corp?
Thinking about buying stock in Livent, Bitfarms, Altus Power, Bright Minds Biosciences, or CEL-SCI Corp? PR Newswire
07.09.22 - PR Newswire
IIROC Trading Halt - CVM
IIROC Trading Halt - CVM Canada NewsWire
20.07.22 - PR Newswire
Thinking about buying stock in Stronghold Digital Mining, Aehr Test Systems, CEL-SCI Corp, HTG Molecular Diagnostics, or Blue Hat Interactive?
Thinking about buying stock in Stronghold Digital Mining, Aehr Test Systems, CEL-SCI Corp, HTG Molecular Diagnostics, or Blue Hat Interactive? PR Newswire
31.08.20 - ACCESSWIRE
CEL-SCI Corporation to Present at The LD 500 Virtual Conference
VIENNA, VA / ACCESSWIRE / August 31, 2020 /  CEL-SCI Corporation (NYSE American:CVM) , a Phase 3 cancer immunotherapy company, today announced that it will be presenting ...
21.01.20 - LYNX Analysen
Cel-Sci als Geheimtipp unter den Biotechnologieaktien?
Jetzt vollständige Analyse lesen

Newssuche

Videos

newspaper
08:35 Uhr -20,59%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »